The DOI matches its Crossref record.
Breast Cancer Metastasis: Challenges and Opportunities
Open accessAbstract
Despite exciting progress in the understanding of breast cancerdevelopment and progression, and in the development of noveltherapeutic strategies, breast cancer remains the second leadingcause of cancer-related death in women, with a yearly toll of morethan 40,000 deaths in the United States alone. Breast cancer–relateddeaths are mainly due to the “incurable” nature of metastaticbreast cancer (MBC) at the current time. It is estimated that?6% of patients have metastatic disease at the time of diagnosisand 20% to 50% patients first diagnosed with primary breast cancerwill eventually develop metastatic disease. Even with the remarkableadvances in research and clinical management, thecurrent treatment strategies for breast cancer metastasis stilllargely rely on the use of systemic cytotoxic agents, which frequentlydeteriorate the patient's life quality due to severe sideeffects and, in many cases, have limited long-term success. Theprognosis for MBC patients is poor, with an estimated 5-year survivalof only 26%. Therefore, MBC remains the most challengingtask facing both cancer researcher and oncologist. To tackle thischallenge, scientists and physicians of the Breast Cancer ResearchProgram at the M.D. Anderson Cancer Center held a symposium to(a) provide a better understanding of breast cancer metastasis atthe molecular and cellular level; (b) introduce cutting-edge technologiesin metastatic breast cancer detection, including clinicopathologicdetection, circulating tumor cells (CTC) detection, andadvanced imaging; and (c) solicit innovative ideas in basic, translationalresearch and clinical patient management. The symposiumled to a positive consensus notion that we will be able to prevent,and to a lesser degree, treat metastasis and ultimately save mostpatients from metastatic deaths in the foreseeable future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Collective cell guidance by cooperative intercellular forces
Tambe, D. T., Corey Hardin, C., Angelini, T. E., Rajendran, K., Park, C. Y., Serra-Picamal, X., Zhou, E. H., Zaman, M. H., Butler, J. P., Weitz, D. A., et al. (2011) · Nature Materials · doi:10.1038/nmat3025 · Cited by 884
Altered calcium signaling in cancer cells
Stewart, T. A., Yapa, K. T. D. S., & Monteith, G. R. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.08.016 · Cited by 337
Global analysis of advanced/metastatic breast cancer: decade report (2005-2015)
Cardoso, F., Spence, D., Mertz, S., Corneliussen-James, D., Sabelko, K., Gralow, J., Cardoso, M.-J., Peccatori, F., Paonessa, D., Benares, A., et al. (2018) · The Breast · doi:10.1016/j.breast.2018.03.002 · Cited by 324
MRI detection of breast cancer micrometastases with a fibronectin-targeting contrast agent
Zhou, Z., Qutaish, M., Han, Z., Schur, R. M., Liu, Y., Wilson, D. L., & Lu, Z.-R. (2015) · Nature Communications · doi:10.1038/ncomms8984 · Cited by 260
Lee, W. H., Choong, L. Y., Jin, T. H., Mon, N. N., Chong, S., Liew, C. S., Putti, T., Lu, S. Y., Harteneck, C., & Lim, Y. P. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.39 · Cited by 121
Metadata
- Authors
- Lu, J., Steeg, P. S., Price, J. E., Krishnamurthy, S., Mani, S. A., Reuben, J., Cristofanilli, M., Dontu, G., Bidaut, L., Valero, V., Hortobagyi, G. N., & Yu, D.
- Venue
- Cancer Research
- Published
- 2009-06-15
- Volume
- 69
- Issue
- 12
- Pages
- 4951-4953
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2040512792
- Cited by
- 251
- References
- 0
- FWCI
- 2.98
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Breast Cancer Metastasis: Challenges and Opportunities. https://app.cochat.ai/papers/10.1158/0008-5472.can-09-0099
- The paper
- Lu, J., Steeg, P. S., Price, J. E., Krishnamurthy, S., Mani, S. A., Reuben, J., Cristofanilli, M., Dontu, G., Bidaut, L., Valero, V., Hortobagyi, G. N., & Yu, D. (2009). Breast Cancer Metastasis: Challenges and Opportunities. Cancer Research. https://doi.org/10.1158/0008-5472.can-09-0099
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.